Kimble L. Jenkins insider trades: ClearPoint Neuro (CLPT) SEC Form 4 filings
Companies
Where Kimble reports to the SEC
Other CLPT insiders
Open-market trades in the last 12 months
About Kimble L. Jenkins's insider trades
Kimble L. Jenkins is a director at ClearPoint Neuro (CLPT). Kimble has not reported an open-market purchase or sale.
Their filings also include grants and awards (29 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CLPT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.